Equity Overview
Price & Market Data
Price: $0.502
Daily Change: $0.00 / 0.00%
Daily Range: $0.502 - $0.502
Market Cap: $39,172,024
Daily Volume: 505
Performance Metrics
1 Week: -3.27%
1 Month: 0.55%
3 Months: 6.01%
6 Months: 16.66%
1 Year: 19.46%
YTD: 10.44%
Details
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other neurological conditions. Its technology includes ExoPTEN for the treatment of acute spinal cord injury and glaucoma; and Exosomes as a drug delivery system for regeneration and healing of specific tissues. The company was founded in 2020 and is based in Toronto, Canada.